Filing Flows › Sotera Health (SHC) › Stock forecast & fair value
Sotera Health (SHC) stock forecast and fair value
Sotera Health (SHC) trades at $18.15. 9 analysts' median price target is $22.00 (+21%), from $15.00 to $25.00. Across 17 valuation methods the middle fair value is $5.21 (-71%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| P/E vs peers | $9.91 | $14.79 | $17.72 | -19% |
| P/E vs peers, weighted | $8.26 | $11.21 | $16.27 | -38% |
| P/E vs peers, matched | $9.51 | $14.79 | $18.07 | -19% |
| P/E vs peers, growth-adjusted | $8.67 | $12.40 | $17.72 | -32% |
| EV/Sales vs peers | −$1.45 | $1.59 | $5.36 | -91% |
| EV/Sales vs peers, weighted | −$0.73 | $1.58 | $3.40 | -91% |
| EV/Sales vs peers, matched | −$1.84 | $0.69 | $4.28 | -96% |
| Residual income | $3.64 | $3.77 | $3.91 | -79% |
| Analysts' price targets | $15.00 | $21.94 | $25.00 | +21% |
| Owner earnings capitalized | $4.64 | $5.21 | $5.94 | -71% |
Sotera Health's latest quarter
Sotera Health, Q3 2026: revenue $325M (+4% year over year), operating margin 25.8%, net earnings $58.4M, operating cash flow $111M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for SHC stock?
The median of 9 analysts' 12-month targets is $22.00, +21% from $18.15; the range is $15.00 to $25.00. The average rating is buy.
What is Sotera Health's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $0.00 and $21.94, with a middle value of $5.21 against a price of $18.15. Each method's assumptions are on the page.
Does Sotera Health usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is SHC stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.